variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele,getev_report_url
GJB2-M34T,GJB2,"Several labs have reported in ClinVar that this causes deafness in a recessive manner: http://www.ncbi.nlm.nih.gov/clinvar/variation/17000/ This variant seems to be ""mild"", with a stronger effect when combined with a more severe variant. The variant is relatively common: according to ExAC data, 1 in 40 with European ancestry (and 1 in 25 Finnish) are carriers of this variant. Löppönen et al 2012 report that homozygotes for the variant have mild to moderate hearing impairment.",Moderate,Well-established,Pathogenic,0.0099,Hearing and vision,Recessive,Heterozygous,22668073,rs35887622,5,chr13,20763620,G,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
HABP2-G534E,HABP2,"Known as the ""Marburg I"" polymorphism, this variant is associated with increased risk of coronary heart disease (CHD) in individuals with elevated cholesterol, triglyceride, and fibrinogen levels (5-fold risk of a CHD event, compared to 2-fold risk increase in people with the same risk factors but do not have this variant). In individuals without these elevated levels, however, carriers of the variant do not appear to have any increased risk of CHD.",Moderate,Likely,Pathogenic,0.028,Heart and circulatory;Metabolism,Unknown,Heterozygous,15543324;22421107,rs7080536,3,chr10,115348046,A,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
PRF1-A91V,PRF1,"This variant may be associated with a slightly increased susceptibility to some rare blood disorders, in particular autoimmune proliferative disease, if combined with a more severe mutation elsewhere. Most reports lack statistical significance.",Low,Likely,Pathogenic,0.033,Blood;Immune system,Complex/Other,Heterozygous,16720836;17311987;17475905,rs35947132,1,chr10,72360387,A,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
rs5186,,"This common noncoding genetic variant has an allele frequency of ~30% and is associated with an increased risk of hypertension. If ~25% of non-carriers have hypertension, Bonnardeaux et al's data predict ~4% increased risk of hypertension per copy of this variant. This SNP is in the 3' noncoding region of the AGTR1 transcript (angiotensin II type 1 receptor), also known as AT2R1 or AT1R, which is a target of hypertension drugs.",Low,Likely,Pathogenic,0.21,Drug response;Heart and circulatory,Unknown,Heterozygous,"8021009;
11250978;11593098;16046653;16675453;17668390",rs5186,2,chr3,148459988,C,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
RET-R982C,RET,"Initially suspected of causing Hirschsprung’s disease, this rare variant has been later reported as present in unaffected controls (allele frequency around 1%). Supporting a lack of effect: Panini et al. did not find loss of function effects seen in other variants, and Svensson et al. report unaffected relatives in a family who carried the same variant. OMIM lists it as reported to cause increased susceptibility, but there do not appear to be any statistically significant reports supporting this hypothesis.",Low,Uncertain,Pathogenic,0.016,Other,Dominant,Heterozygous,7647787;7881414;9760196;14633923,rs17158558,2,chr10,43620335,T,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
BRCA2-N372H,BRCA2,"This is a common variant of BRCA2 (HapMap allele frequency of 23%). The variant is weakly associated with an increased chance of breast cancer, and zygosity of the variant is associated with sex of children: male children are more likely to be homozygous for this variant, female children are more likely to be heterozygous.",Low,Uncertain,Pathogenic,0.24,Cancer,Recessive,Homozygous,11062481;15235023,rs144848,2,chr13,32906729,C,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
TGFB1-R25P,TGFB1,"This variant in a growth factor gene is associated with variation in TGFB1 levels; this has been associated with various pathogenic and some protective effects, including: more hepatic fibrosis progression in hep C patients, lower risk of cleft palate, anticorrelation with longevity, higher risk of myocardial infarction and lower risk of hypertension.",Low,Uncertain,Pathogenic,0.049,Anatomical and congenital;Heart and circulatory,Complex/Other,Heterozygous,8901839;14596813;15212689;15569360,rs1800471,2,chr19,41858876,G,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
POLG-Q1236H,POLG,"Generally a nonpathogenic polymorphism, but may have a modifier effect that increases severity when combined in cis with other pathogenic variants.",Low,Uncertain,Pathogenic,0.058,Other,Complex/Other,Heterozygous,15917273;16595552,rs3087374,0,chr15,89859994,A,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
LRP5-A1330V,LRP5,"In a study of a UK population this variant was associated with a small increased risk of osteoporosis and osteoporotic bone fractures, with each copy of the variant presumed to have an additive effect. A study in Chinese young men failed to find an association with peak bone density.

 
",Low,Uncertain,Pathogenic,0.11,"Muscular, skeletal, and connective tissue",Complex/Other,Heterozygous,18455228;19148563;20953208,rs3736228,2,chr11,68201295,T,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
TGIF1-P83Shift,TGIF1,"Severe variants in this gene are associated with holoprosencephaly disorders when combined with loss-of-function variants in SHH. Haploinsufficiency was identified in some families with this condition. It is unclear how likely this variant is to occur in combination with an SHH variant, or what phenotypic effect the variant would have on its own.",Low,Uncertain,Pathogenic,0.14,Nervous system,Complex/Other,Heterozygous,10556296,rs11571510,1,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
ELAC2-S217L,ELAC2,"Reported to be associated with increased susceptibility to prostate cancer, but later studies weaken the hypothesis. Xu et al.'s meta-analysis concludes that there is a small but significant increased risk (OR = 1.13). Assuming a lifetime risk of 16% for prostate cancer we calculate this leads to an increased risk of ~1.5% (17.5% total).",Low,Uncertain,Pathogenic,0.27,Cancer;Genital and urinary,Complex/Other,Heterozygous,12384782;15368467;18767027;20231859,rs4792311,2,chr17,12915009,A,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
ACAD8-S171C,ACAD8,"This variant (a.k.a S149C) was found as a compound heterozygote (with M130T) in a male newborn of European descent with isobutyryl-CoA dehydrogenase deficiency (identified by newborn screening). Lack of controls means that significance cannot be established and allele frequency cannot be estimated. Oglesbee et al. comment that IBD-deficiency may be relatively benign, most cases identified by newborn screening have remained asymptomatic, but Ferreira et al. report a symptomatic individual homozygous for this variant.",Low,Uncertain,Pathogenic,0.018,Metabolism,Recessive,Heterozygous,17304052;18677552,rs113488591,0,chr11,134128923,G,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
ELAC2-A541T,ELAC2,"This variant is implicated as causing increased susceptibility to prostate cancer. However the variant has always been seen paired with S217L, it is unclear which variant is causal. Evidence is weak for both; one meta-analysis (Severi et al.) concluded that neither variant was pathogenic, a more recent meta-analysis (Xu et al.) found the data to be significant but the odds ratio was not strong and concluded they are ""low-penetrance susceptibility markers of prostate cancer"".",Low,Uncertain,Pathogenic,0.028,Cancer;Genital and urinary,Unknown,Heterozygous,10986046;11175785;11431329;12373607;12515253;12783937;18767027;20231859,rs34152967,2,chr17,12899902,T,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
WFS1-R611H,WFS1,"This nonsynonymous SNP is associated with Wolfram Syndrome (known as DIDMOAD), which is characterized by early-onset non-autoimmune diabetes mellitus, diabetes insipidus, optic atrophy, and deafness) and to adult Type Two Diabetes Mellitus.  The WFS1 gene maps to chromosome 4p16.3.  The variant has been shown to be statistically associated with type II diabetes in six UK studies and one study of Ashkenazi Jews (Sandhu, M., et al., Minton et al.).",Low,Uncertain,Not Reviewed,0.4,Hearing and vision;Immune system;Metabolism,Recessive,Heterozygous,17603484;17719176;23257691,rs734312,1,chr4,6303354,A,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
SP110-L425S,SP110,"This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.",Low,Uncertain,Pathogenic,0.86,Immune system,Unknown,Homozygous,16803959,rs3948464,1,chr2,231050715,G,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
TP53-P72R,TP53,"This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.",Low,Uncertain,Pathogenic,0.63,Cancer,Unknown,Homozygous,1975675;9607760;15355915;19837266;20615891;22184967,rs1042522,0,chr17,7579472,C,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
DPYD-M166V,DPYD,Associated with DPYD deficiency and poor prognosis for chemotherapy w/ 5-flurorouracil. ,High,Likely,Pharmacogenetic,0.078,Other,Unknown,Heterozygous,11895907;14635116;19104657,rs2297595,5,chr1,98165091,C,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
TPMT-Y240C,TPMT,"Alone, this variant is known as TPMT*3C -- but often, especially in Caucasians, it is found together with another nonsynonymous variant (A154T) to produce the TPMT*3A variant. Both variants are associated with loss of thiopurine methyltransferase (TPMT) activity, although *3C is milder than *3A. Inability to metabolize thiopurine drugs can lead to severe adverse reactions. Heterozygotes may be advised to take a reduced dosage due to reduced metabolism of the drug.",Low,Well-established,Pharmacogenetic,0.046,Drug response;Metabolism,Complex/Other,Heterozygous,15228163;15298741;20154640;20354201,rs1142345,2,chr6,18130918,C,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
TPMT-A154T,TPMT,"Usually this variant is found in combination Y240C, forming the TPMT*3A variant. When alone, this variant produces the *3B variant. Both variants are associated with loss of thiopurine methyltransferase (TPMT) activity. Inability to metabolize thiopurine drugs can lead to severe adverse reactions. Heterozygotes may be advised to take a reduced dosage due to reduced metabolism of the drug.",Low,Likely,Pharmacogenetic,0.028,Drug response;Metabolism,Recessive,Heterozygous,15228163;15298741;20154640;20354201,rs1800460,2,chr6,18139228,T,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
FUT2-W154X,FUT2,"This recessive protective variant confers resistance to norovirus (which causes stomach flu). 20% of Caucasians and Africans are homozygous for this variant and are ""non-secretors"": they do not express ABO blood type antigens in their saliva or mucosal surfaces. Most strains of norovirus bind to these antigens in the gut, and so this non-secretor status confers almost total resistantance to most types of norovirus. There are notable exceptions, some strains of norovirus bind a different target and are equally infectious for secretors and non-secretors.",Moderate,Well-established,Protective,0.49,Blood;Immune system,Recessive,Heterozygous,7876235;12692541;19625485;20031047;22025362,rs601338,5,chr19,49206674,A,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
PRNP-M129V,PRNP,"This variant is associated with some protective effects for prion disease -- individuals homozygous for this variant are less susceptible to Creutzfeldt-Jakob, and Papua New Guinea individuals heterozygotes at this site are less susceptible to kuru.

",Low,Well-established,Protective,0.34,Other,Complex/Other,Heterozygous,18236005;19081515,rs1799990,0,chr20,4680251,G,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
CFH-V62I,CFH,"Associated with a decreased risk for age related macular degeneration (ARMD). Homozygotes for this have a 4-5% decreased attributable risk (3-4% vs. average 8% risk), heterozygotes have slightly lower than average risk (7%). Non-carriers have an increased risk (12-13%). ARMD impairs sharp vision as age progresses. While there is no cure, treatment can slow progression of the disease and environmental factors (smoking and obesity) contribute to higher risk.",Low,Likely,Protective,0.39,Hearing and vision;Metabolism,Complex/Other,Heterozygous,15870199,rs800292,2,chr1,196642233,A,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
KCNJ11-K23E,KCNJ11,"This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.",Low,Likely,Protective,0.74,Metabolism,Unknown,Homozygous,17463246;17463248;20054294,rs5219,2,chr11,17409572,C,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
MTR-D919G,MTR,"This variant was weakly associated with a protective effect vs. colorectal cancer, but only in individuals with low alcohol consumption.


",Low,Uncertain,Protective,0.22,Cancer,Complex/Other,Heterozygous,10498402;14744749;17417062;17855192,rs1805087,1,chr1,237048500,G,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
COL9A2-T246M,COL9A2,Probably benign.,Low,Likely,Benign,0.025,Other,Unknown,Heterozygous,11565064,rs2228565,,chr1,40775937,A,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
NEFL-S472Shift,NEFL,"Although a frameshift in this gene would be predicted to cause Charcot-Marie Neuropathy, this particular position appears to reflect a single base insertion error/mutation in the reference genome (in other words, normal individuals are always homozygous for a deletion at this position relative to reference). See chr8:24,811,060-24,811,080 annotations on UCSC.",Low,Likely,Benign,,Nervous system,Unknown,Homozygous,,rs11340767,,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
DMD-R2155W,DMD,Probably benign.,Low,Likely,Benign,0.027,Other,Unknown,Heterozygous,9298822,rs1800273,,chrX,31986607,A,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
PMS2-P470S,PMS2,"Benign, common variant.",Low,Likely,Benign,0.37,Other,Unknown,Heterozygous,15256438,rs1805321,,chr7,6026988,A,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
FBN2-S2580L,FBN2,"Probably benign -- initially associated with congenital contractual arachnodactyly, but later reports classify it as a nonpathogenic polymorphism.",Low,Uncertain,Benign,0.078,Anatomical and congenital,Dominant,Heterozygous,9714438;10633129;16835936;17345643,rs2291628,,chr5,127609633,A,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
MLH1-I219V,MLH1,"Computational evidence, functional assays, and case/control studies suggest this variant is probably benign.",Low,Uncertain,Benign,0.24,Other,Dominant,Heterozygous,11781295;12810663;17074586;17510385;17870204;19863800;20301390;22631669,rs1799977,0,chr3,37053568,G,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
LOXL1-R141L,LOXL1,"Associated with exfoliative glaucoma & syndrome (XFG & XFS) in various populations, but with contradicting results (protective in Caucasians, pathogenic in Japanese). Based on this it seems the variation itself -- although it affects protein structure -- is not itself causing disease. Instead it is likely associated with other nearby causal variants. As such, it is evaluated as benign by GET-Evidence (which focuses on reporting causal variants). See detailed variant report for disease risk associations.",Low,Uncertain,Benign,0.26,Hearing and vision,Complex/Other,Heterozygous,17690259;18450598;20142848,rs1048661,,chr15,74219546,T,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
RPGRIP1-A547S,RPGRIP1,"Probably benign. Implicated in causing autosomal recessive cone-rod dystrophy, but a later report found the same incidence in controls and concludes it is not causal.",Low,Uncertain,Benign,0.23,Hearing and vision,Complex/Other,Heterozygous,12920076;16272259,rs10151259,,chr14,21790040,T,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
ERCC6-R1230P,ERCC6,Probably benign.,Low,Uncertain,Benign,0.07,Other,Unknown,Heterozygous,,rs4253211,,chr10,50678317,G,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
PTCH1-P1315L,PTCH1,"Common polymorphism, presumed benign.",Low,Uncertain,Benign,0.3,Other,Unknown,Heterozygous,15712338,rs357564,,chr9,98209594,A,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
MAPT-R370W,MAPT,Probably benign.,Low,Uncertain,Benign,0.16,Other,Unknown,Heterozygous,15365985,rs17651549,,chr17,44061278,T,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
FLG-R3530S,FLG,"Tentatively classified as benign, although predicted by Polyphen 2 to be damaging. Other more severe null mutations (frameshift and nonsense) in this gene are reported to cause ichthyosis vulgaris in a recessive manner.",Low,Uncertain,Benign,0.11,Skin,Unknown,Heterozygous,,rs72697000,,chr1,152276772,A,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
DSP-R1537C,DSP,Probably benign / nonpathogenic.,Low,Uncertain,Benign,0.01,Other,Unknown,Heterozygous,20152563,rs28763967,,chr6,7581032,T,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Homozygous,19351729,rs505151,,chr1,55529187,A,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
RP1-N985Y,RP1,"Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.",Low,Uncertain,Benign,0.35,Metabolism,Unknown,Heterozygous,12764676;19364639,rs2293869,,chr8,55539395,T,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
TYR-S192Y,TYR,This variant is reported to affect skin pigmentation. It is associated with lighter skin in South Asians (OR 4-5) and with a lack of freckles in Europeans (OR 1.3).,Low,Uncertain,Benign,0.27,Skin,Unknown,Heterozygous,17952075;17999355,rs1042602,,chr11,88911696,A,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
TPCN2-G734E,TPCN2,Pigmentation allele.,Low,Uncertain,Benign,0.29,Other,Unknown,Homozygous,18488028,rs3829241,,chr11,68855363,A,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
SLC45A2-L374F,SLC45A2,"Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.",Low,Uncertain,Benign,0.69,Cancer,Unknown,Homozygous,15714523;17044855;18563784;18806926,rs16891982,,chr5,33951693,G,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
WFS1-R456H,WFS1,Reported benign in ClinVar,Low,Uncertain,Benign,0.045,Other,Unknown,Heterozygous,,rs1801208,0,chr4,6302889,A,http://evidence.pgp-hms.org/genomes?display_genome_id=0b4cb7a1d159516fe70ad20d80c7e8c38773462c
